ID   RFWD3_HUMAN             Reviewed;         774 AA.
AC   Q6PCD5; A8K585; B2RE35; D3DUJ8; Q5XKR3; Q9H9Q3; Q9NVT4;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 3.
DT   10-MAY-2017, entry version 128.
DE   RecName: Full=E3 ubiquitin-protein ligase RFWD3;
DE            EC=2.3.2.27;
DE   AltName: Full=RING finger and WD repeat domain-containing protein 3;
DE   AltName: Full=RING finger protein 201;
DE   AltName: Full=RING-type E3 ubiquitin transferase RFWD3 {ECO:0000305};
GN   Name=RFWD3; Synonyms=RNF201;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-564.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LYS-392 AND
RP   THR-770.
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   FUNCTION, INTERACTION WITH MDM2 AND TP53, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION AT SER-46 AND SER-63, AND MUTAGENESIS OF SER-46;
RP   SER-63 AND CYS-315.
RX   PubMed=20173098; DOI=10.1073/pnas.0912094107;
RA   Fu X., Yucer N., Liu S., Li M., Yi P., Mu J.J., Yang T., Chu J.,
RA   Jung S.Y., O'Malley B.W., Gu W., Qin J., Wang Y.;
RT   "RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53
RT   stability in response to DNA damage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:4579-4584(2010).
RN   [7]
RP   FUNCTION, INTERACTION WITH RPA2, AND SUBCELLULAR LOCATION.
RX   PubMed=21504906; DOI=10.1074/jbc.M111.222869;
RA   Gong Z., Chen J.;
RT   "E3 ligase RFWD3 participates in replication checkpoint control.";
RL   J. Biol. Chem. 286:22308-22313(2011).
RN   [8]
RP   FUNCTION, INTERACTION WITH RPA2, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF CYS-315.
RX   PubMed=21558276; DOI=10.1074/jbc.M111.222802;
RA   Liu S., Chu J., Yucer N., Leng M., Wang S.Y., Chen B.P.,
RA   Hittelman W.N., Wang Y.;
RT   "RING finger and WD repeat domain 3 (RFWD3) associates with
RT   replication protein A (RPA) and facilitates RPA-mediated DNA damage
RT   response.";
RL   J. Biol. Chem. 286:22314-22322(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates the
CC       ubiquitination of p53/TP53 in the late response to DNA damage, and
CC       acts as a positive regulator of p53/TP53 stability, thereby
CC       regulating the G1/S DNA damage checkpoint. May act by catalyzing
CC       the formation of short polyubiquitin chains on p53/TP53 that are
CC       not targeted to the proteasome. In response to ionizing radiation,
CC       interacts with MDM2 and enhances p53/TP53 ubiquitination, possibly
CC       by restricting MDM2 from extending polyubiquitin chains on
CC       ubiquitinated p53/TP53. Plays a role in RPA-mediated DNA damage
CC       signaling and repair. {ECO:0000269|PubMed:20173098,
CC       ECO:0000269|PubMed:21504906, ECO:0000269|PubMed:21558276}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with MDM2 and p53/TP53. Binds to the RPA
CC       complex via direct interaction with RPA2.
CC       {ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:21504906,
CC       ECO:0000269|PubMed:21558276}.
CC   -!- INTERACTION:
CC       P61088:UBE2N; NbExp=2; IntAct=EBI-2129159, EBI-1052908;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, PML body. Cytoplasm.
CC       Note=In undamaged cells, found both in the cytoplasm and in the
CC       nucleus, partially associated with PML nuclear bodies. In response
CC       to replication block, such as that caused by hydroxyurea
CC       treatment, or to DNA damage caused by ionizing radiations or
CC       doxorubicin, recruited to the nucleus, to stalled replication
CC       forks or to sites of DNA repair. This recruitment depends upon
CC       RPA2.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated in the S-G2 phase.
CC       {ECO:0000269|PubMed:21558276}.
CC   -!- DOMAIN: The coiled coil domain may be involved in RPA2-binding.
CC   -!- PTM: Phosphorylated at Ser-46 and Ser-63 upon DNA damage by ATM or
CC       ATR. ATM phosphorylation occurs at early times upon DNA damage,
CC       while ATR is the major kinase at later times. Phosphorylation by
CC       ATM and ATR is required to stabilize p53/TP53. Part of the
CC       phosphorylation depends upon RPA2 presence.
CC       {ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:21558276}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91662.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAF83889.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG38132.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001382; BAA91662.1; ALT_INIT; mRNA.
DR   EMBL; AK022673; BAB14169.1; -; mRNA.
DR   EMBL; AK291200; BAF83889.1; ALT_INIT; mRNA.
DR   EMBL; AK315786; BAG38132.1; ALT_INIT; mRNA.
DR   EMBL; AC109599; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471114; EAW95680.1; -; Genomic_DNA.
DR   EMBL; CH471114; EAW95681.1; -; Genomic_DNA.
DR   EMBL; BC002574; AAH02574.2; -; mRNA.
DR   EMBL; BC059371; AAH59371.2; -; mRNA.
DR   CCDS; CCDS32486.1; -.
DR   RefSeq; NP_060594.3; NM_018124.3.
DR   RefSeq; XP_005256078.1; XM_005256021.4.
DR   RefSeq; XP_005256079.1; XM_005256022.4.
DR   RefSeq; XP_011521493.1; XM_011523191.2.
DR   RefSeq; XP_016878880.1; XM_017023391.1.
DR   UniGene; Hs.567525; -.
DR   ProteinModelPortal; Q6PCD5; -.
DR   SMR; Q6PCD5; -.
DR   BioGrid; 120460; 51.
DR   DIP; DIP-52688N; -.
DR   IntAct; Q6PCD5; 39.
DR   STRING; 9606.ENSP00000354361; -.
DR   iPTMnet; Q6PCD5; -.
DR   PhosphoSitePlus; Q6PCD5; -.
DR   BioMuta; RFWD3; -.
DR   DMDM; 126253679; -.
DR   EPD; Q6PCD5; -.
DR   MaxQB; Q6PCD5; -.
DR   PaxDb; Q6PCD5; -.
DR   PeptideAtlas; Q6PCD5; -.
DR   PRIDE; Q6PCD5; -.
DR   Ensembl; ENST00000361070; ENSP00000354361; ENSG00000168411.
DR   Ensembl; ENST00000571750; ENSP00000460049; ENSG00000168411.
DR   GeneID; 55159; -.
DR   KEGG; hsa:55159; -.
DR   UCSC; uc002fda.4; human.
DR   CTD; 55159; -.
DR   DisGeNET; 55159; -.
DR   GeneCards; RFWD3; -.
DR   H-InvDB; HIX0013236; -.
DR   HGNC; HGNC:25539; RFWD3.
DR   HPA; HPA048258; -.
DR   HPA; HPA075649; -.
DR   MIM; 614151; gene.
DR   neXtProt; NX_Q6PCD5; -.
DR   OpenTargets; ENSG00000168411; -.
DR   PharmGKB; PA134960063; -.
DR   eggNOG; KOG1645; Eukaryota.
DR   eggNOG; ENOG410XPPE; LUCA.
DR   GeneTree; ENSGT00390000008931; -.
DR   HOVERGEN; HBG093895; -.
DR   InParanoid; Q6PCD5; -.
DR   KO; K15691; -.
DR   OMA; ILCEFQA; -.
DR   OrthoDB; EOG091G05D0; -.
DR   PhylomeDB; Q6PCD5; -.
DR   TreeFam; TF323359; -.
DR   SignaLink; Q6PCD5; -.
DR   UniPathway; UPA00143; -.
DR   GenomeRNAi; 55159; -.
DR   PRO; PR:Q6PCD5; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000168411; -.
DR   CleanEx; HS_RFWD3; -.
DR   ExpressionAtlas; Q6PCD5; baseline and differential.
DR   Genevisible; Q6PCD5; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0097371; F:MDM2/MDM4 family protein binding; IPI:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IPI:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0031571; P:mitotic G1 DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:2000001; P:regulation of DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00320; WD40; 3.
DR   SUPFAM; SSF50978; SSF50978; 2.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Complete proteome; Cytoplasm; DNA damage; DNA repair;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation pathway;
KW   WD repeat; Zinc; Zinc-finger.
FT   CHAIN         1    774       E3 ubiquitin-protein ligase RFWD3.
FT                                /FTId=PRO_0000278234.
FT   REPEAT      495    537       WD 1.
FT   REPEAT      539    577       WD 2.
FT   REPEAT      583    628       WD 3.
FT   ZN_FING     287    331       RING-type; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   COILED      361    413       {ECO:0000255}.
FT   MOD_RES      46     46       Phosphoserine; by ATM and ATR.
FT                                {ECO:0000269|PubMed:20173098}.
FT   MOD_RES      63     63       Phosphoserine; by ATM and ATR.
FT                                {ECO:0000269|PubMed:20173098}.
FT   VARIANT      90     90       T -> N (in dbSNP:rs8058922).
FT                                /FTId=VAR_030700.
FT   VARIANT     392    392       R -> K (in dbSNP:rs17854997).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030701.
FT   VARIANT     564    564       I -> V (in dbSNP:rs7193541).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_030702.
FT   VARIANT     770    770       I -> T (in dbSNP:rs17854996).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030703.
FT   MUTAGEN      46     46       S->A: Markedly decreases phosphorylation
FT                                following ionizing radiation and
FT                                abolishes ability to stimulate p53/TP53
FT                                ubiquitination; when associated with A-
FT                                63. {ECO:0000269|PubMed:20173098}.
FT   MUTAGEN      63     63       S->A: Markedly decreases phosphorylation
FT                                following ionizing radiation and
FT                                abolishes ability to stimulate p53/TP53
FT                                ubiquitination; when associated with A-
FT                                46. {ECO:0000269|PubMed:20173098}.
FT   MUTAGEN     315    315       C->A: Abolishes ability to stimulate
FT                                p53/TP53 ubiquitination. No effect on
FT                                nuclear localization in response to DNA
FT                                damage. {ECO:0000269|PubMed:20173098,
FT                                ECO:0000269|PubMed:21558276}.
FT   CONFLICT    221    221       S -> P (in Ref. 1; BAF83889).
FT                                {ECO:0000305}.
FT   CONFLICT    552    552       A -> T (in Ref. 1; BAA91662).
FT                                {ECO:0000305}.
FT   CONFLICT    597    597       A -> V (in Ref. 1; BAA91662).
FT                                {ECO:0000305}.
FT   CONFLICT    741    741       Q -> R (in Ref. 1; BAB14169).
FT                                {ECO:0000305}.
SQ   SEQUENCE   774 AA;  85094 MW;  EF6E0E186FD2E580 CRC64;
     MAHEAMEYDV QVQLNHAEQQ PAPAGMASSQ GGPALLQPVP ADVVSSQGVP SILQPAPAEV
     ISSQATPPLL QPAPQLSVDL TEVEVLGEDT VENINPRTSE QHRQGSDGNH TIPASSLHSM
     TNFISGLQRL HGMLEFLRPS SSNHSVGPMR TRRRVSASRR ARAGGSQRTD SARLRAPLDA
     YFQVSRTQPD LPATTYDSET RNPVSEELQV SSSSDSDSDS SAEYGGVVDQ AEESGAVILE
     EQLAGVSAEQ EVTCIDGGKT LPKQPSPQKS EPLLPSASMD EEEGDTCTIC LEQWTNAGDH
     RLSALRCGHL FGYRCISTWL KGQVRKCPQC NKKARHSDIV VLYARTLRAL DTSEQERMKS
     SLLKEQMLRK QAELESAQCR LQLQVLTDKC TRLQRRVQDL QKLTSHQSQN LQQPRGSQAW
     VLSCSPSSQG QHKHKYHFQK TFTVSQAGNC RIMAYCDALS CLVISQPSPQ ASFLPGFGVK
     MLSTANMKSS QYIPMHGKQI RGLAFSSYLR GLLLSASLDN TIKLTSLETN TVVQTYNAGR
     PVWSCCWCLD EANYIYAGLA NGSILVYDVR NTSSHVQELV AQKARCPLVS LSYMPRAASA
     AFPYGGVLAG TLEDASFWEQ KMDFSHWPHV LPLEPGGCID FQTENSSRHC LVTYRPDKNH
     TTIRSVLMEM SYRLDDTGNP ICSCQPVHTF FGGPTCKLLT KNAIFQSPEN DGNILVCTGD
     EAANSALLWD AASGSLLQDL QTDQPVLDIC PFEVNRNSYL ATLTEKMVHI YKWE
//
